Tag: Breast cancer

HealthcareInnovation

AstraZeneca-Daiichi Sankyo Cancer Drug Shows Breakthrough Results in Early Breast Cancer Treatment

AstraZeneca and Daiichi Sankyo’s targeted cancer therapy Enhertu has demonstrated remarkable efficacy in early-stage breast cancer treatment. According to recent trial data, the drug reduced recurrence risk by 53% and showed superior complete response rates compared to standard therapies, potentially transforming treatment approaches for HER2-positive breast cancer patients.

Breakthrough Results in Early-Stage Breast Cancer

New clinical trial data presented at the European Society for Medical Oncology Congress indicates that AstraZeneca and Daiichi Sankyo’s drug Enhertu has shown promising results in treating early-stage HER2-positive breast cancer, according to reports from the medical conference. The findings suggest the drug, currently approved for advanced cancers, could represent a significant advancement toward curative treatment for patients in earlier disease stages.

by Carter Wells
HealthcareTechnology

Blood Test Breakthrough Offers New Hope for Early Cancer Detection

A Stanford-trained engineer has pioneered a blood test that can detect colon cancer through DNA fragments. The FDA-approved technology represents a significant advancement in liquid biopsies and could transform routine cancer screening.

The Engineering Approach to Cancer Detection

According to reports from Business Insider, a Silicon Valley engineer has developed a blood test capable of detecting colon cancer through analyzing cancer DNA fragments in the bloodstream. Helmy Eltoukhy, co-CEO of Guardant and Stanford electrical engineering alumnus, reportedly approached cancer detection as an engineering challenge after witnessing the “diagnostic odyssey” patients endure.

by Carter Wells
BusinessTechnology

Private Equity Giants TPG and Blackstone Finalize Acquisition of Medical Tech Firm Hologic

Two of the world’s largest private equity firms are closing in on a major acquisition of medical technology company Hologic. The deal represents one of the most significant take-private transactions in the healthcare sector this year, according to sources familiar with the matter.

Major Healthcare Acquisition Nears Completion

Private equity firms Blackstone and TPG are reportedly finalizing a deal to acquire medical technology company Hologic in what sources indicate could be one of the largest take-private transactions of the year. According to people familiar with the negotiations, an announcement could come as early as next week, with both firms having agreed on terms and secured debt financing for the acquisition.

by Darren Holt